At @ weeks , @ ( @ % ) of @ patients in the efavirenz @ mg group and @ ( @ % ) of @ in the efavirenz @ mg group had a plasma HIV-@ viral load less than @ copies per mL ( difference -@ , @ % CI -@ to @ ; p = @ ) , which suggests continued non-inferiority of the lower efavirenz dose .